(RTTNews) - CapsoVision, Inc. (CV), a commercial-stage medical technology company developing imaging and AI-enabled capsule endoscopy solutions, announced the submission of its 510(k) application to ...
Gastrointestinal (GI) diseases, whose symptoms can be varied and painful, may lead to serious health problems, and present a formidable health challenge throughout the world. For these diseases, early ...
Bangalore is home to some of India’s most accomplished gastroenterologists, offering world-class treatment for digestive and ...
From major acquisitions to AI-powered partnerships, here are 10 major GI deals to know from 2025: 1. In January, Optum subsidiary SCA Health, one of the largest ASC chains in the country, acquired ...
News-Medical.Net on MSN
A pill that confirms you actually swallowed your medicine
SAFARI capsule technology offers a novel solution for medication adherence, using a dissolvable Faraday cage to verify ...
SARATOGA, Calif. - CapsoVision, Inc. (NASDAQ:CV) has submitted a 510(k) application to the Food and Drug Administration for its AI-assisted module for the CapsoCam Plus capsule endoscopy system, the ...
Saurin P1 lesions were linked with an increased risk for rebleeding in patients with suspected small bowel bleeding, when ...
SAVANNAH, Ga. (WTOC) - Doctors at Memorial Hospital in Savannah are helping patients ditch medication and live indigestion ...
A research team at Tohoku University, in collaboration with Denka Company Limited and U-A Corporation, has developed a ...
Small intestine cancer occurs when abnormal cells grow in the tissues of the small bowel, the long tube that connects your ...
CapsoVision, Inc. CV recently announced that it has submitted a 510(k) application to the FDA for approval to add an AI-based reading feature to its CapsoCam Plus capsule endoscopy system. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback